Literature DB >> 30096073

Increasing prevalence of self-reported HIV preexposure prophylaxis use in published surveys: a systematic review and meta-analysis.

Emiko Kamitani1,2, Megan E Wichser3, Adebukola H Adegbite3, Mary M Mullins1, Wayne D Johnson1, Pierre-Cedric Crouch4, Theresa Ann Sipe1.   

Abstract

: When combining results from all published surveys, about one in nine global study participants (10.7%) reported ever using preexposure prophylaxis (PrEP) by 2017, a significant increase since US FDA approval in 2012 [odds ratio (OR) = 1.6/year, P < 0.00001]. Moreover, nearly one in six US-based study participants (17.3%) and nearly one in four MSM who met the Centers for Disease Control and Prevention's PrEP indications (24.5%) reported ever using PrEP by 2016. The odds of reporting PrEP use are approximately doubling each year (OR = 1.8/year, P < 0.00001; OR = 2.0/year, P < 0.00001).

Entities:  

Mesh：

Year:  2018        PMID： 30096073      PMCID： PMC6704375          DOI： 10.1097/QAD.0000000000001983

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  13 in total

1.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

Review 2.  Prevalence of Depression, Depressive Symptoms, and Suicidal Ideation Among Medical Students: A Systematic Review and Meta-Analysis.

Authors:  Lisa S Rotenstein; Marco A Ramos; Matthew Torre; J Bradley Segal; Michael J Peluso; Constance Guille; Srijan Sen; Douglas A Mata
Journal:  JAMA       Date:  2016-12-06       Impact factor: 56.272

3.  Impact of the Centers for Disease Control's HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States.

Authors:  Samuel M Jenness; Steven M Goodreau; Eli Rosenberg; Emily N Beylerian; Karen W Hoover; Dawn K Smith; Patrick Sullivan
Journal:  J Infect Dis       Date:  2016-07-14       Impact factor: 5.226

4.  Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC.

Authors:  Irene Kuo; Halli Olsen; Rudy Patrick; Gregory Phillips; Manya Magnus; Jenevieve Opoku; Anthony Rawls; James Peterson; Flora Hamilton; Michael Kharfen; Alan Greenberg
Journal:  Drug Alcohol Depend       Date:  2016-03-15       Impact factor: 4.492

5.  Reaching Key Populations: PrEP Uptake in an Urban Health Care System in the Bronx, New York.

Authors:  Cedric H Bien; Viraj V Patel; Oni J Blackstock; Uriel R Felsen
Journal:  AIDS Behav       Date:  2017-05

6.  Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.

Authors:  Albert Y Liu; Stephanie E Cohen; Eric Vittinghoff; Peter L Anderson; Susanne Doblecki-Lewis; Oliver Bacon; Wairimu Chege; Brian S Postle; Tim Matheson; K Rivet Amico; Teri Liegler; M Keith Rawlings; Nikole Trainor; Robert Wilder Blue; Yannine Estrada; Megan E Coleman; Gabriel Cardenas; Daniel J Feaster; Robert Grant; Susan S Philip; Richard Elion; Susan Buchbinder; Michael A Kolber
Journal:  JAMA Intern Med       Date:  2016-01       Impact factor: 21.873

7.  Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.

Authors:  Dawn K Smith; Michelle Van Handel; Richard J Wolitski; Jo Ellen Stryker; H Irene Hall; Joseph Prejean; Linda J Koenig; Linda A Valleroy
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-11-27       Impact factor: 17.586

8.  Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol.

Authors:  Elmira Gheytanchi; Zahra Madjd; Leila Janani; Arezoo Rasti; Roya Ghods; Fatemeh Atyabi; Mohammad Hossein Asadi-Lari; Sadegh Babashah
Journal:  Syst Rev       Date:  2017-11-17

Review 9.  Prevalence of Depression and Depressive Symptoms Among Resident Physicians: A Systematic Review and Meta-analysis.

Authors:  Douglas A Mata; Marco A Ramos; Narinder Bansal; Rida Khan; Constance Guille; Emanuele Di Angelantonio; Srijan Sen
Journal:  JAMA       Date:  2015-12-08       Impact factor: 56.272

10.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

Authors:  Sheena McCormack; David T Dunn; Monica Desai; David I Dolling; Mitzy Gafos; Richard Gilson; Ann K Sullivan; Amanda Clarke; Iain Reeves; Gabriel Schembri; Nicola Mackie; Christine Bowman; Charles J Lacey; Vanessa Apea; Michael Brady; Julie Fox; Stephen Taylor; Simone Antonucci; Saye H Khoo; James Rooney; Anthony Nardone; Martin Fisher; Alan McOwan; Andrew N Phillips; Anne M Johnson; Brian Gazzard; Owen N Gill
Journal:  Lancet       Date:  2015-09-09       Impact factor: 79.321
View more
  11 in total

1.  Awareness, Willingness, and Perceived Efficacy of Pre-exposure Prophylaxis among Adolescent Sexual Minority Males.

Authors:  Alvin Gordián-Arroyo; Robert Garofalo; Lisa M Kuhns; Cynthia Pearson; Josh Bruce; D Scott Batey; Asa Radix; Uri Belkind; Marco A Hidalgo; Sabina Hirshfield; Eric W Schrimshaw; Rebecca Schnall
Journal:  J Urban Health       Date:  2020-10       Impact factor: 3.671

2.  Projected Impact of Concurrently Available Long-Acting Injectable and Daily-Oral Human Immunodeficiency Virus Preexposure Prophylaxis: A Mathematical Model.

Authors:  Kevin M Maloney; Adrien Le Guillou; Robert A Driggers; Supriya Sarkar; Emeli J Anderson; Amyn A Malik; Samuel M Jenness
Journal:  J Infect Dis       Date:  2021-01-04       Impact factor: 5.226

Review 3.  Mapping the Study Characteristics and Topics of HIV Pre-Exposure Prophylaxis Research Literature: A Scoping Review.

Authors:  Emiko Kamitani; Yuko Mizuno; Megan Wichser; Adebukola H Adegbite; Julia B DeLuca; Darrel H Higa
Journal:  AIDS Educ Prev       Date:  2019-12

4.  The Influence of Relationship Dynamics and Sexual Agreements on Perceived Partner Support and Benefit of PrEP Use Among Same-Sex Male Couples in the U.S.

Authors:  Erin M Kahle; Akshay Sharma; Stephen Sullivan; Rob Stephenson
Journal:  AIDS Behav       Date:  2020-07

5.  Research Synthesis, HIV Prevention Response, and Public Health: CDC's HIV/AIDS Prevention Research Synthesis Project.

Authors:  Linda J Koenig; Cynthia M Lyles; Darrel Higa; Mary M Mullins; Theresa A Sipe
Journal:  Public Health Rep       Date:  2021-02-26       Impact factor: 2.792

6.  Sociodemographic Characteristics of HIV Pre-Exposure Prophylaxis Use and Reasons for Nonuse Among Gay, Bisexual, and Other Men Who Have Sex with Men from Three US Cities.

Authors:  Krishna Kiran Kota; Gordon Mansergh; Rob Stephenson; Sabina Hirshfield; Patrick Sullivan
Journal:  AIDS Patient Care STDS       Date:  2021-04-23       Impact factor: 5.078

7.  PrEP Interest Among Men Who Have Sex with Men in the Netherlands: Covariates and Differences Across Samples.

Authors:  Mart van Dijk; Sascha B Duken; Rosemary M Delabre; Richard Stranz; Vincent Schlegel; Daniela Rojas Castro; Adeline Bernier; Paul Zantkuijl; Robert A C Ruiter; John B F de Wit; Kai J Jonas
Journal:  Arch Sex Behav       Date:  2020-03-02

8.  Use of, and likelihood of using, HIV pre-exposure prophylaxis among men who have sex with men in Europe and Central Asia: findings from a 2017 large geosocial networking application survey.

Authors:  Adam Bourne; Beatrice Alba; Alex Garner; Gianfranco Spiteri; Anastasia Pharris; Teymur Noori
Journal:  Sex Transm Infect       Date:  2019-01-05       Impact factor: 3.519

9.  HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular health.

Authors:  Simon B Ascher; Rebecca Scherzer; Michelle M Estrella; Judy Shigenaga; Kimberly A Spaulding; David V Glidden; Megha L Mehrotra; Patricia Defechereux; Monica Gandhi; Robert M Grant; Michael G Shlipak; Vasantha Jotwani
Journal:  AIDS       Date:  2020-04-01       Impact factor: 4.632

10.  Growth in Proportion and Disparities of HIV PrEP Use Among Key Populations Identified in the United States National Goals: Systematic Review and Meta-analysis of Published Surveys.

Authors:  Emiko Kamitani; Wayne D Johnson; Megan E Wichser; Adebukola H Adegbite; Mary M Mullins; Theresa Ann Sipe
Journal:  J Acquir Immune Defic Syndr       Date:  2020-08-01       Impact factor: 3.771
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.